---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-21-000179"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2021-07-07T23:59:59+00:00"
generated_at: "2026-06-30T06:48:20.265984+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics appoints Cardoza as President & COO, Lab Ops; Wallar as President, Pharma Services

## Summary
- George A. Cardoza appointed President and COO, Lab Operations effective July 5, 2021; base salary $500k, bonus target 60%.
- Dr. Gina M. Wallar appointed President, Pharma Services effective July 5, 2021; base salary $370k, bonus target 50%.
- Cardoza awarded equity valued at $1M (7,584 restricted shares + option for 40,502 shares); Wallar awarded $250k equity.
- Both appointments are internal promotions; Cardoza previously CFO and President Pharma Services, Wallar previously SVP Sales.

## SEC filing metadata
- accession: 0001077183-21-000179
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2021-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/neo-20210705.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-21-000179
- JSON: https://secwatch.observer/filing/0001077183-21-000179.json
- Plain text: https://secwatch.observer/filing/0001077183-21-000179.txt

## Key facts
- Executive change
  Gina M. Wallar was appointed as President, Pharma Services Division at NEOGENOMICS INC.
  - Action: appointed
  - Role: President, Pharma Services Division
  source text: The Company announces that Dr. Gina M. Wallar, age 46, has been appointed President, Pharma Services Division effective July 5, 2021 to replace the vacancy left by Mr. Cardoza's assumption of his new position.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm
- Executive change
  George A. Cardoza was appointed as President and Chief Operating Officer, Lab Operations at NEOGENOMICS INC.
  - Action: appointed
  - Role: President and Chief Operating Officer, Lab Operations
  source text: NeoGenomics, Inc. (the “Company”) announces that George A. Cardoza, age 59, has been appointed President and Chief Operating Officer, Lab Operations effective July 5, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1077183/000107718321000179/0001077183-21-000179-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.